Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Samsung Medical Center · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
pembrolizumabtriple-negative-breast-cancertumor-microenvironment
triple negative breast cancer, neoadjuvant chemotherapy, pembrolizumab, tumor microenvironment, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 966339
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.